Unusual 11 Mid-Day Movers 5/26: MAPP, CYTK, OXGN, JMBA Higher; GM, REDF, ALTI, OGXI Lower
Tweet Send to a Friend
MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) 155% HIGHER; announced that the efficacy portion of its first Phase 3 clinical trial evaluating ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
